The future trends in the APIs production

The future trends in the APIs production

“Traditionally, the pharma industry used to separate the two business models, but I believe there is a case for inn...
The making of APIs

The making of APIs

Olon’s ability to develop and manufacture Active Pharmaceutical Ingredients (APIs) in our network of facilities allows clients full access to integrated services resulting in faster production and delivery timelines, with one of the most extensive track records.

Events 2022

In the coming months we will be present at these sector events. The list is constantly updated and may be subject to changes.

Quality

Regulatory inspections

Our facilities are regularly inspected by the most important national and foreign medicine agencies: FDA - Food and Drug Administration (USA), AIFA - Agenzia Italiana del Farmaco (Italy), AEMPS - Agencia Espanola de Medicamentos y productos sanitarios (Spain), Russian Health Authority, PEBC - Pharmacy Examining Board of Canada, COFEPRIS - Comisión Federal para la Protección contra Riesgos Sanitarios (Mexico), TGA - Therapeutic Goods Administration (Australia), PDMA - Pharmaceuticals and Medical Devices Agency (Japan), KFDA - Ministry of Food and Drug Safety (Korea), ANVISA - Agency Nacional de Vigilancia Sanitária (Brazil), WHO - World Health Organization.



2022 Rodano
2018 Settimo
2019 Garbagnate
2020 Mulazzano
2019 Dorno
2020 Segrate
2022 Casaletto
2020 Capua
2022 Derivados Quimicos
2019 Ricerca Bioscience
2022 Olon India